Business Context and Reporting Period
This is an Amendment No. 1 on Form 8-K/A filed by CorMedix Inc. on June 17, 2014, regarding events occurring between May 9, 2014, and June 13, 2014. The filing amends a previous report concerning the resignation of Dr. Gary Gelbfish from the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and director departures.
Material Changes
The primary material change is the clarification of the resignation status of Dr. Gary Gelbfish, who served as Chairman of the Board from August 13, 2013, until May 12, 2014. While an initial report on May 15, 2014, stated he resigned effective May 12, 2014, subsequent communications indicated he did not consider himself resigned at that time. A letter dated June 13, 2014, provided by Dr. Gelbfish, confirmed his resignation was effective as of June 13, 2014.
Outlook, Risks, and Management Commentary
Management noted that during a board meeting on May 12, 2014, Dr. Gelbfish raised issues regarding certain business matters. The company, based on legal counsel, initially determined these did not constitute disagreements requiring disclosure. However, Dr. Gelbfish later communicated disagreements with the company, though specific details were not provided until his June 13, 2014, letter. No financial guidance or operational outlook is included in this filing.
Key Facts for Investor Verification
- Dr. Gary Gelbfish's resignation as Chairman of the Board is effective June 13, 2014, not May 12, 2014.
- Dr. Gelbfish cited unspecified disagreements with the company's operations, policies, or practices.
- The specific nature of the disagreements is detailed in Exhibit 17.1 (Letter from Dr. Gary Gelbfish) attached to the filing.
- Dr. Gelbfish previously served on the Compensation Committee and chaired the Nominating and Governance Committee.